Targeted Therapy

Targeted Therapy

Could this be the future of cancer treatment?

Learn More

Meet Jeff and Tiffany Wigbels

Meet Jeff and Tiffany Wigbels

Learn how their story of heartbreak turned to hope.

Learn More

Dr. Roy S. Herbst

Dr. Roy S. Herbst

As Professor and Chief, Section of Thoracic Medical Oncology, Department of Thoracic/Head and Neck Medical Oncology, Dr. Herbst helps lead the BATTLE against lung cancer.

Learn More

100% to Research

100% to Research

Your donation will have an immediate impact on the fight against cancer.

Learn More

On October 11, 2006, Jeff Wigbels learned he had Stage IV non-smokers lung cancer. The next day, his wife — unaware of this — gave birth to their son. The following day, Jeff told her there was a good chance their son soon might not have a dad. But today, because of the targeted therapy being developed at M. D. Anderson, Jeff is watching his children grow up. He believes he’s been given a gift, one that he and Tiffany want to give back.

Learn more about Jeff, the molecular-level cancer research and treatment that’s helped him beat the odds and the Take Aim at Cancer Research Fund.

News

Sunday, April 18th, at the Washington Convention Center in Washington, D.C., Take Aim at Cancer founder and cancer survivor, Jeff... read more

Cancer survivor and Atlanta businessman Jeff Wigbels officially launched The Wigbels/Herbst Cancer Research Fund (WHCRF) today as the organization’s Board of... read more

Events

World renown artist Jamali partners with Wigbels/Herbst to fight cancer.

Donate now to support targeted-therapy cancer research and treatment.

Survivor Wine - Prepare to toast to your health.

Researching and advancing molecular-level cancer therapy for promising results.